Is Costco Stock Finally Cheap Enough to Buy?

Costco posted accelerating growth despite inflation, with fiscal Q3 sales up 11.6% year over year, comps up 9.4%, and EPS rising to $4.93 from $4.28. May revenue grew 14.5% and comps rose 12.5%, but the stock is down 13% this year as investors worry about valuation at 49x trailing earnings versus a 3-year average of 52x. The article frames Costco as fundamentally strong but still expensive, implying near-term pressure from sentiment and multiple compression.

Analysis

The market is treating COST less like a defensive compounder and more like a bond proxy with equity optionality, which is exactly why multiple compression can persist even while operating fundamentals stay strong. The second-order issue is not demand deterioration; it is duration risk: when a high-quality consumer staple trades at a premium, any small deceleration in growth, even from a still-healthy base, can trigger multiple de-rating faster than earnings can rescue the stock. That makes the next few quarters a valuation/positioning trade more than a fundamental one.

The real winners are likely Costco’s ecosystem partners and adjacent retailers that can capture trade-down traffic if COST remains elevated relative to the market. More interestingly, persistent traffic strength at Costco suggests the low-end consumer is still resilient, which is a negative read-through for discretionary weak links and a positive read-through for private-label, club, and value-oriented channels. If inflation stays sticky, COST can continue taking share, but the stock may underperform because investors already own it as the “quality hedge,” leaving limited incremental upside unless comp trends re-accelerate again.

The contrarian takeaway is that the stock may not be cheap on absolute metrics, but it is now less expensive relative to its own history, and that matters if macro volatility spikes. The setup argues for a time-horizon distinction: over days to weeks, the stock is vulnerable to any normalizing monthly sales print or broader growth-factor selloff; over 12-24 months, recurring membership revenue and pricing power can still compound EPS enough to justify patience. The key question is whether the market continues rewarding reliability or rotates toward cheaper cyclicals as inflation expectations stabilize.

For trading, the cleanest expression is to fade the premium rather than the business: COST is better suited to a tactical short against a value/defensive basket than an outright short. If owning it, use weakness after any in-line report as a phased entry rather than chasing strength, because upside is likely capped unless the market re-rates defensives higher. Any long should be sized as a lower-beta compounder, not a multiple expansion story.

Key Decisions for Investors

• Avoid initiating a fresh outright long in COST at current levels; if already owned, trim 20-30% on strength and keep the remainder as a core defensive compounder with a 12-24 month horizon.
• Pair trade: long COST / short XRT only on market pullbacks if you want to own quality retail dispersion, but keep tight stops because the valuation headwind can overwhelm fundamentals in a risk-on tape.
• More attractive tactical expression: short COST vs. a basket of cheaper defensive grocers/club peers on any post-earnings pop; target 3-5% relative downside over 1-2 months if comps merely meet expectations.
• If macro volatility rises and defensive leadership returns, buy COST only on a 5-8% drawdown from current levels; risk/reward improves materially there versus paying up for near-perfect execution.
• For options, consider a 60-90 day put spread rather than stock shorting if you expect valuation compression to continue; the stock’s fundamental floor is high, but multiple contraction can still deliver a 1.5:1 to 2:1 payoff.